skip to main content

Legionella pneumophila

Legionella pneumophila

Catalogue No.

NCTC 11404

Current Name

Legionella pneumophila

Type Strain

Reference Strain

Original Strain Reference

Bellingham-1, 77-091436

Culture Conditions

Growth Conditions on Solid Media

Buffered Charcoal Yeast Extract agar (BCYE), 48 hours, 37°C, CO₂ required

Biological and Genomic Info

Serogroup/Serotype

Serogroup 1

Gram Stain Result

Negative

Enzyme Tests

Catalase: +

Cytochrome C oxidase: +

Strain Data

R. E. Weaver, CDC Atlanta in 1981 / Washington State Health Dept. / St. Josephs Hospital, Bellingham, USA / Pleural fluid / Serogroup 1

Additional Info

Accession Date

01/01/1981

Depositor

WEAVER R E

Isolated From

human, pleural fluid

History

WEAVER R E, CDC ATLANTA-ISLT ST JOSEPHS HOSP, WASHINGTON CSOR:HORSE BLOOD

Previous Catalogue Name

Legionella pneumophila

Available Formats

  • Ampoule (Bacteria)

If use of this culture results in a scientific publication, it should be cited in the publication as: Legionella pneumophila (NCTC 11404)

It is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.